MicroRNA expression signatures associated with metastatic progression in papillary thyroid carcinoma
Authors:
- Vinicius Ferreira Capelli CapelliVCVinicius Ferreira Capelli Capelli
- Ana Kober LeiteALAna Kober Leite
- Kelly Cristina SaitoKSKelly Cristina Saito
- Thérèse Rachell TheodoroTTThérèse Rachell Theodoro
- Fátima Solange PasiniFPFátima Solange Pasini
- Venâncio Avancini Ferreira AlvesVAVenâncio Avancini Ferreira Alves
- Luiz Paulo KowalskiLuiz Paulo Kowalski
- Maria Aparecida Silva PinhalMPMaria Aparecida Silva Pinhal
- Edna Teruko KimuraEKEdna Teruko Kimura
- Leandro Luongo MatosLMLeandro Luongo Matos
Open Access
- 1 January 2026
- journal article
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (4) , 1-9
Abstract
The objective of this study is to compare the miRNA expression profiles of primary tumors and matched metastatic lesions from patients who died due to progression of metastatic PTC. We conducted an exploratory study of patients with PTC who died from disease progression and had tissue samples available from both primary tumors and distant metastases. Total RNA was extracted and analyzed to assess the expression of 64 preselected miRNAs. Expression data were normalized using endogenous controls (let-7g-5p and miR-181a-5p), and differential expression was calculated using the 2-∆Ct method. Those miRNAs detected in < 70% of samples or with cycle threshold (Ct) > 36 were excluded. Univariate analyses were performed using paired tests, and multivariate results were adjusted for multiple comparisons using the Benjamini-Hochberg false discovery rate (FDR) method. Out of 3,555 patients treated for PTC between 1986 and 2015, eight patients were included. Univariate analysis identified five miRNAs differentially expressed in metastatic lesions: let-7e-5p, miR-10b-5p, miR-30e-3p, miR-423-5p, and miR-483-3p. After multivariate adjustment, miR-10b-5p and miR-30e-3p remained independently overexpressed in metastatic tissues. This study is one of the first to demonstrate distinct miRNA expression profiles in metastatic versus primary tumors in fatal PTC cases. The identified miRNAs are known to regulate processes such as cell migration, invasion, and apoptosis in other cancers, suggesting their potential contribution to PTC metastasis.Keywords
This publication has 16 references indexed in Scilit:
- The prognostic and diagnostic values of MicroRNA-10b in gastric cancerMedicine, 2020
- Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade GliomaWorld Neurosurgery, 2019
- Tumor suppressor function of miR‑483‑3p on breast cancer via targeting of the cyclin E1 geneExperimental and Therapeutic Medicine, 2018
- miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomasLaboratory Investigation, 2017
- Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancerOncotarget, 2016
- IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancerOncotarget, 2016
- Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinomaTumor Biology, 2015
- Faculty Opinions recommendation of High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.2013
- MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancerFEBS Letters, 2010
- Oncogenic Role of miR-483-3p at the IGF2/483 LocusCancer Research, 2010